Two- and three-dimensional quantitative structure–activity relationships for a series of purine nucleoside phosphorylase inhibitors

Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen

Gareth Jones, Peter Willett, Robert C. Glen et al. · Journal of Molecular Biology · 1997 · 6.7K citations

Pharmacy, Bioinformatics, Medicinal Chemistry +14

Improved protein–ligand docking using GOLD

Marcel L. Verdonk, Jason C. Cole, Michael J. Hartshorn et al. · Proteins Structure Function and Bioinformatics · 2003 · 3K citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure–activity relationship

Marek Murias, Norbert Handler, Thomas Erker et al. · Bioorganic & Medicinal Chemistry · 2004 · 288 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(Arylmethyl) derivatives of 9-deazaguanine

John A. Montgomery, Shri Niwas, Jerry D. Rose et al. · Journal of Medicinal Chemistry · 1993 · 132 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Calf Spleen Purine Nucleoside Phosphorylase Complexed with Substrates and Substrate Analogues^,

Chen Mao, William J. Cook, Min Zhou et al. · Biochemistry · 1998 · 103 citations

Life Sciences, Biochemistry, Molecular Biology +15